(Q83765725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Tyrphostin AG490 reduces NAPDH oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein E-deficient mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Ioana M Fenyo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Irina C Florea

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Monica Raicu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Adrian Manea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

30 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

3-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

100-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

NOX5 variants are functionally active in endothelial cells

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Transcriptional regulation of the NADPH oxidase isoform, Nox1, in colon epithelial cells: role of GATA-binding factor(s).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Novel aspects of oxidative stress in cardiovascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Interferon-gamma activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

NOX enzymes as novel targets for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Introduction to JAK/STAT signaling and the vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

JAK-STAT signaling: from interferons to cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Peroxisomes and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Implications of early structural-functional changes in the endothelium for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.006

10.1016/J.VPH.2011.03.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21457788%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference